查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830736

2025年化學冷光免疫檢測全球市場報告

Chemiluminescence Immunoassay Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，化學冷光免疫檢測市場規模強勁成長，從2024年的136.3億美元增加至2025年的148.5億美元，複合年成長率為8.9%。預測期內的成長可歸因於對高靈敏度檢測技術的日益關注、化學冷光分析與就地檢驗設備的日益融合、對多重檢測能力的需求不斷成長、化學冷光在腫瘤診斷中的應用不斷擴大以及感染疾病的流行率不斷上升。

預計未來幾年化學冷光免疫檢測市場規模將強勁成長，到2029年將達到206.4億美元，複合年成長率為8.6%。預測期內的成長可歸因於個人化醫療需求的不斷成長、數位醫療技術的日益普及、醫療基礎設施投資的不斷增加、感染疾病診斷應用的不斷擴展以及自動化中心實驗室環境的不斷發展。這段時期的主要趨勢包括：自動化免疫檢測平台的演進、多重化學冷光免疫檢測技術的開發、照護現場解決方案的創新、人工智慧在結果解讀中的應用整合，以及化學化學冷光免疫檢測在個人化醫療中的日益廣泛的應用。

化學冷光免疫檢測(CLIA) 是一種生化技術，可透過將抗原-抗體相互作用與化學冷光訊號結合，用於檢測和定量特定分子，例如蛋白質、荷爾蒙和病原體。此方法透過測量化學反應過程中產生的光來確定目標分析物的存在和濃度。它能夠進行靈敏、特異性且快速的診斷檢測，並廣泛應用於臨床和研究領域。

化學冷光免疫檢測的主要產品類型包括分析儀、套件和試劑。分析儀是一種自動化設備，透過檢測和測量反應過程中發出的光來進行化學發光免疫分析 (CLIA) 檢測。這些系統相容於多種樣本類型，包括血液、唾液和尿液，並採用不同的技術，包括化學冷光酵素免疫分析法(CLEIA)、化學冷光免疫檢測(ECLI)和微粒化學化學冷光免疫檢測。 CLIA 應用包括治療藥物監測、腫瘤學、心臟病學、內分泌學、感染疾病和循環系統疾病，服務於廣泛的最終用戶，包括醫院、製藥公司、生物技術公司和臨床實驗室。

2025年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了嚴重影響，特別是對關鍵醫療設備、診斷設備和藥品的供應。醫院和醫療機構面臨進口手術器械、影像設備以及注射器和導管等消耗品成本上漲的問題。這些成本上漲給醫療保健預算帶來了壓力，導致一些醫療機構推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅阻礙了基本藥品和醫療設備的生產，造成了供應鏈瓶頸。作為應對措施，該行業正在籌資策略多樣化，盡可能促進本地生產，並倡導對緊急醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供化學冷光免疫檢測分析市場統計數據，例如全球市場規模、區域佔有率、競爭對手的化學冷光免疫檢測分析市場佔有率、詳細的化學冷光免疫檢測市場細分、市場趨勢和機遇，以及您在化學冷光化學冷光免疫檢測化學冷光免疫檢測對該行業的現狀和未來趨勢進行了詳細分析，為您提供免疫檢測的一切觀點。

預計感染疾病的日益普及將在未來幾年推動化學冷光免疫檢測市場的成長。感染疾病是由細菌、病毒、真菌和寄生蟲等有害微生物引起的疾病，可在人與人之間直接或間接傳播。抗生素抗藥性的上升加劇了這一趨勢，因為它降低了常用治療方法的有效性，並使感染疾病持續存在和蔓延。化學冷光免疫測量透過靈敏和特異性的生物標記檢測來支持感染疾病的診斷，從而能夠及早準確地識別病原體。這些檢測有助於減少診斷延遲、改善患者管理並提高治療效果。例如，2024 年 2 月，英國衛生安全局報告稱，到 2023 年，英格蘭的結核病病例將增加到 4,850 例，比 2022 年的 4,380 例增加 10.7%。因此，感染疾病的日益普及正在推動對化學冷光免疫檢測的需求。

化學冷光免疫檢測市場的主要參與者正在開發先進產品，例如高性能化學冷光免疫檢測分析儀，以提高診斷準確性、增加通量並在各種臨床應用中快速提供結果。這些分析儀可自動檢測和測量化學反應過程中發出的光，以準確識別特定的生物標記。例如，2023 年 7 月，中國生物技術公司 Fapon Biotech Inc. 推出了 Shine i8000/9000 分析儀。它專為中大型實驗室設計，可在 10 分鐘內提供初步結果，並以緊湊、方便用戶使用的設計提供高精度。主要功能包括大型 360 度顯示器、一鍵式批量裝載反應杯、雙管備用基材系統以及自動反應杯處理以最大限度地減少污染。全自動工作流程減少了人工，先進的演算法確保了一致的結果，使其成為大容量診斷環境的理想選擇。

2023年12月，美國生命科學和診斷公司丹納赫集團（Danaher Corporation）以約57億美元收購了Abcam Limited。此次收購增強了丹納赫生命科學部門的實力，使其能夠利用Abcam經過驗證的抗體、試劑、生物標記和檢測方法，加速藥物研發和疾病譜分析，同時使Abcam能夠獨立運作。 Abcam Limited是一家總部位於英國的生命科學公司，專注於化學冷光免疫檢測套件和試劑。

化學冷光免疫檢測市場由提供高靈敏度診斷測試、疾病生物標記檢測、臨床實驗室工作流程最佳化和個人化醫療診斷等服務的營業單位獲得的收益所構成。市場價值還包括服務供應商銷售或包含在其服務產品中的相關產品的價值。化學冷光免疫檢測市場包括用於執行基於化學冷光的診斷測試的免疫檢測分析儀、控制和校準溶液、診斷耗材以及相關配件的銷售。該市場中的商品價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球化學冷光免疫檢測：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球化學冷光免疫檢測市場：成長率分析
  • 全球化學冷光免疫檢測市場表現：規模與成長，2019-2024
  • 全球化學冷光免疫檢測市場預測：規模與成長，2024-2029年，2034年
  • 全球化學冷光免疫檢測：總潛在市場（TAM）

第6章 市場細分

  • 全球化學冷光免疫檢測市場：依產品類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 分析器
  • 套件
  • 試劑
  • 全球化學冷光免疫檢測市場（按樣本類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 血
  • 唾液
  • 尿
  • 其他樣品
  • 全球化學冷光免疫檢測市場：依技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 化學冷光酶技術（CLEIA）
  • 化學冷光免疫檢測（ECLI）
  • 微粒化學化學冷光免疫檢測
  • 全球化學冷光免疫檢測市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 治療藥物監測
  • 腫瘤學
  • 心臟病學
  • 內分泌學
  • 感染疾病
  • 自體免疫疾病
  • 其他用途
  • 全球化學冷光免疫檢測市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 製藥和生物技術公司
  • 臨床實驗室
  • 其他最終用戶
  • 全球化學冷光免疫檢測市場：按分析儀類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 全自動分析儀
  • 半自動分析儀
  • 可攜式分析儀
  • 全球化學冷光免疫檢測市場：套件類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 檢測試劑套件
  • 定量試劑套件
  • 定性試劑套件
  • 多參數套件
  • 全球化學冷光免疫檢測市場：按試劑類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 魯米諾試劑
  • 異魯米諾試劑
  • 吖啶酯試劑
  • 其他試劑

第7章 區域和國家分析

  • 全球化學冷光免疫檢測市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球化學冷光免疫檢測市場：依國家/地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 化學冷光免疫檢測市場：競爭格局
  • 化學冷光免疫檢測市場：公司簡介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Revvity Inc.
  • DiaSorin SpA
  • Tecan Group Ltd.
  • Euroimmun AG
  • Randox Laboratories Ltd.
  • Autobio Diagnostics Co. Ltd.
  • Wondfo Biotech Co. Ltd.
  • Fujirebio Diagnostics Inc.
  • Trivitron Healthcare Pvt. Ltd.
  • Getein Biotech Inc.
  • Fapon Biotech Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年化學冷光免疫檢測市場：提供新機會的國家
  • 2029年化學冷光免疫檢測市場：細分領域帶來新機會
  • 2029年化學冷光免疫檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37723

Chemiluminescence immunoassay (CLIA) is a biochemical technique used to detect and quantify specific molecules, such as proteins, hormones, or pathogens, by combining antigen-antibody interactions with a chemiluminescent signal. In this method, light generated during a chemical reaction is measured to determine the presence and concentration of the target analyte. It offers highly sensitive, specific, and rapid diagnostic testing for both clinical and research applications.

The main product categories in chemiluminescence immunoassay include analyzers, kits, and reagents. Analyzers are automated instruments designed to perform CLIA tests by detecting and measuring the emitted light during the reaction. These systems handle various sample types, such as blood, saliva, urine, and others, and employ different technologies, including chemiluminescence enzyme immunoassay (CLEIA), electrochemiluminescence immunoassay (ECLI), and microparticle chemiluminescence immunoassay. CLIA finds applications in therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious diseases, autoimmune disorders, and more, serving a wide range of end users including hospitals, pharmaceutical and biotech companies, and clinical laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The chemiluminescence immunoassay market research report is one of a series of new reports from The Business Research Company that provides chemiluminescence immunoassay market statistics, including chemiluminescence immunoassay industry global market size, regional shares, competitors with a chemiluminescence immunoassay market share, detailed chemiluminescence immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the chemiluminescence immunoassay industry. This chemiluminescence immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chemiluminescence immunoassay market size has grown strongly in recent years. It will grow from $13.63 billion in 2024 to $14.85 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be credited to the increasing emphasis on high-sensitivity detection techniques, the expanding integration of chemiluminescence assays with point-of-care testing devices, rising demand for multiplex assay capabilities, growing use of chemiluminescence in oncology diagnostics, and the increasing prevalence of infectious diseases.

The chemiluminescence immunoassay market size is expected to see strong growth in the next few years. It will grow to $20.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, greater adoption of digital health technologies, rising investments in healthcare infrastructure, expanding applications in infectious disease diagnostics, and growth in automated central laboratory environments. Key trends during this period include advancements in automated immunoassay platforms, development of multiplex chemiluminescence immunoassay technologies, innovations in point-of-care diagnostic solutions, integration of AI for result interpretation, and the expanding use of chemiluminescence immunoassays in personalized medicine.

The increasing prevalence of infectious diseases is expected to drive growth in the chemiluminescence immunoassay market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly between individuals. The rise in antimicrobial resistance is contributing to this trend, as it diminishes the effectiveness of common treatments, allowing infections to persist and spread. Chemiluminescence immunoassays support infectious disease diagnosis by providing highly sensitive and specific biomarker detection, enabling early and accurate identification of pathogens. These assays help reduce diagnostic delays, improve patient management, and enhance treatment outcomes. For instance, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England rose to 4,850 in 2023, up 10.7% from 4,380 cases in 2022. Therefore, the increasing prevalence of infectious diseases is boosting demand for chemiluminescence immunoassays.

Key players in the chemiluminescence immunoassay market are developing advanced products, such as high-performance chemiluminescence immunoassay analyzers, to improve diagnostic accuracy, increase throughput, and deliver faster results across a variety of clinical applications. These analyzers automatically detect and measure light emitted during chemical reactions to identify specific biomarkers with precision. For example, in July 2023, Fapon Biotech Inc., a China-based biotechnology company, launched the Shine i8000/9000 analyzer. Designed for medium to large laboratories, it provides preliminary results within 10 minutes and offers high precision with a compact, user-friendly design. Key features include a 360-degree large-span display, one-touch bulk loading for reaction cups, a dual-tube backup substrate system, and automatic reaction cup disposal to minimize contamination. Its fully automated workflow reduces manual intervention, while advanced algorithms ensure consistent results, making it ideal for high-volume diagnostic settings.

In December 2023, Danaher Corporation, a US-based life sciences and diagnostics company, acquired Abcam Limited for approximately \$5.7 billion. The acquisition strengthens Danaher's Life Sciences segment by leveraging Abcam's validated antibodies, reagents, biomarkers, and assays to accelerate drug discovery and disease mapping, while allowing Abcam to operate independently. Abcam Limited is a UK-based life sciences company specializing in chemiluminescence immunoassay kits and reagents.

Major players in the chemiluminescence immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Revvity Inc., DiaSorin S.p.A., Tecan Group Ltd., Euroimmun AG, Randox Laboratories Ltd., Autobio Diagnostics Co. Ltd., Wondfo Biotech Co. Ltd., Fujirebio Diagnostics Inc., Trivitron Healthcare Pvt. Ltd., Getein Biotech Inc., Fapon Biotech Inc., Diazyme Laboratories Inc

North America was the largest region in the chemiluminescence immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chemiluminescence immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chemiluminescence immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chemiluminescence immunoassay market consists of revenues earned by entities by providing services such as high-sensitivity diagnostic testing, disease biomarker detection, clinical laboratory workflow optimization, and personalized healthcare diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The chemiluminescence immunoassay market also includes sales of immunoassay analyzers, control and calibration solutions, diagnostic consumables, and related accessories used for performing chemiluminescence-based diagnostic tests. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chemiluminescence Immunoassay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chemiluminescence immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chemiluminescence immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chemiluminescence immunoassay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Analyzers; Kits; Reagents
  • 2) By Sample Type: Blood; Saliva; Urine; Other Samples
  • 3) By Technology: Chemiluminescence Enzyme Technology (CLEIA); Electrochemiluminescence Immunoassay (ECLI); Microparticle Chemiluminescence Immunoassay
  • 4) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease; Autoimmune Disease; Other Applications
  • 5) By End-User: Hospitals; Pharmaceutical And Biotechnology Companies; Clinical Laboratories; Other End-Users
  • Subsegments:
  • 1) By Analyzers: Fully Automated Analyzers; Semi Automated Analyzers; Portable Analyzers
  • 2) By Kits: Detection Kits; Quantitative Kits; Qualitative Kits; Multiparameter Kits
  • 3) By Reagents: Luminol Reagents; Isoluminol Reagents; Acridinium Ester Reagents; Other Reagents
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; QuidelOrtho Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; Revvity Inc.; DiaSorin S.p.A.; Tecan Group Ltd.; Euroimmun AG; Randox Laboratories Ltd.; Autobio Diagnostics Co. Ltd.; Wondfo Biotech Co. Ltd.; Fujirebio Diagnostics Inc.; Trivitron Healthcare Pvt. Ltd.; Getein Biotech Inc.; Fapon Biotech Inc.; Diazyme Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chemiluminescence Immunoassay Market Characteristics

3. Chemiluminescence Immunoassay Market Trends And Strategies

4. Chemiluminescence Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Chemiluminescence Immunoassay Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Chemiluminescence Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Chemiluminescence Immunoassay Market Growth Rate Analysis
  • 5.4. Global Chemiluminescence Immunoassay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Chemiluminescence Immunoassay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Chemiluminescence Immunoassay Total Addressable Market (TAM)

6. Chemiluminescence Immunoassay Market Segmentation

  • 6.1. Global Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Analyzers
  • Kits
  • Reagents
  • 6.2. Global Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Saliva
  • Urine
  • Other Samples
  • 6.3. Global Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chemiluminescence Enzyme Technology (CLEIA)
  • Electrochemiluminescence Immunoassay (ECLI)
  • Microparticle Chemiluminescence Immunoassay
  • 6.4. Global Chemiluminescence Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease
  • Autoimmune Disease
  • Other Applications
  • 6.5. Global Chemiluminescence Immunoassay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Pharmaceutical And Biotechnology Companies
  • Clinical Laboratories
  • Other End-Users
  • 6.6. Global Chemiluminescence Immunoassay Market, Sub-Segmentation Of Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fully Automated Analyzers
  • Semi Automated Analyzers
  • Portable Analyzers
  • 6.7. Global Chemiluminescence Immunoassay Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Detection Kits
  • Quantitative Kits
  • Qualitative Kits
  • Multiparameter Kits
  • 6.8. Global Chemiluminescence Immunoassay Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Luminol Reagents
  • Isoluminol Reagents
  • Acridinium Ester Reagents
  • Other Reagents

7. Chemiluminescence Immunoassay Market Regional And Country Analysis

  • 7.1. Global Chemiluminescence Immunoassay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Chemiluminescence Immunoassay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chemiluminescence Immunoassay Market

  • 8.1. Asia-Pacific Chemiluminescence Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chemiluminescence Immunoassay Market

  • 9.1. China Chemiluminescence Immunoassay Market Overview
  • 9.2. China Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chemiluminescence Immunoassay Market

  • 10.1. India Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chemiluminescence Immunoassay Market

  • 11.1. Japan Chemiluminescence Immunoassay Market Overview
  • 11.2. Japan Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chemiluminescence Immunoassay Market

  • 12.1. Australia Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chemiluminescence Immunoassay Market

  • 13.1. Indonesia Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chemiluminescence Immunoassay Market

  • 14.1. South Korea Chemiluminescence Immunoassay Market Overview
  • 14.2. South Korea Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chemiluminescence Immunoassay Market

  • 15.1. Western Europe Chemiluminescence Immunoassay Market Overview
  • 15.2. Western Europe Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chemiluminescence Immunoassay Market

  • 16.1. UK Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chemiluminescence Immunoassay Market

  • 17.1. Germany Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chemiluminescence Immunoassay Market

  • 18.1. France Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chemiluminescence Immunoassay Market

  • 19.1. Italy Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chemiluminescence Immunoassay Market

  • 20.1. Spain Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chemiluminescence Immunoassay Market

  • 21.1. Eastern Europe Chemiluminescence Immunoassay Market Overview
  • 21.2. Eastern Europe Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chemiluminescence Immunoassay Market

  • 22.1. Russia Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chemiluminescence Immunoassay Market

  • 23.1. North America Chemiluminescence Immunoassay Market Overview
  • 23.2. North America Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chemiluminescence Immunoassay Market

  • 24.1. USA Chemiluminescence Immunoassay Market Overview
  • 24.2. USA Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chemiluminescence Immunoassay Market

  • 25.1. Canada Chemiluminescence Immunoassay Market Overview
  • 25.2. Canada Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chemiluminescence Immunoassay Market

  • 26.1. South America Chemiluminescence Immunoassay Market Overview
  • 26.2. South America Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chemiluminescence Immunoassay Market

  • 27.1. Brazil Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chemiluminescence Immunoassay Market

  • 28.1. Middle East Chemiluminescence Immunoassay Market Overview
  • 28.2. Middle East Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chemiluminescence Immunoassay Market

  • 29.1. Africa Chemiluminescence Immunoassay Market Overview
  • 29.2. Africa Chemiluminescence Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Chemiluminescence Immunoassay Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Chemiluminescence Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chemiluminescence Immunoassay Market Competitive Landscape And Company Profiles

  • 30.1. Chemiluminescence Immunoassay Market Competitive Landscape
  • 30.2. Chemiluminescence Immunoassay Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Chemiluminescence Immunoassay Market Other Major And Innovative Companies

  • 31.1. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.2. QuidelOrtho Corporation
  • 31.3. Sysmex Corporation
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Revvity Inc.
  • 31.6. DiaSorin S.p.A.
  • 31.7. Tecan Group Ltd.
  • 31.8. Euroimmun AG
  • 31.9. Randox Laboratories Ltd.
  • 31.10. Autobio Diagnostics Co. Ltd.
  • 31.11. Wondfo Biotech Co. Ltd.
  • 31.12. Fujirebio Diagnostics Inc.
  • 31.13. Trivitron Healthcare Pvt. Ltd.
  • 31.14. Getein Biotech Inc.
  • 31.15. Fapon Biotech Inc.

32. Global Chemiluminescence Immunoassay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chemiluminescence Immunoassay Market

34. Recent Developments In The Chemiluminescence Immunoassay Market

35. Chemiluminescence Immunoassay Market High Potential Countries, Segments and Strategies

  • 35.1 Chemiluminescence Immunoassay Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Chemiluminescence Immunoassay Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Chemiluminescence Immunoassay Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer